| 03/07/2019 |
J. Scott Daniels, PhD, Joins BASi as Senior Vice President of DMPK, Filling Key Scientific Leadership Position
|
| 02/21/2019 |
BASi Appoints Joe Flynn as Chief Commercial Officer
|
| 02/15/2019 |
BASi Appoints Senior Contract Research Executive, D. Thomas Oakley, as Chief Operating Officer
|
| 01/16/2019 |
BASi Elects Entrepreneur, Who Has Led BASi Turnaround and Recent Growth, as President and Chief Executive Officer and a Director
|
| 11/01/2018 |
BASi Names John E. Sagartz Chief Strategy Officer
|
| 10/17/2018 |
BASi Breaks Ground on Expansion of GLP Toxicology Facility in Indiana
|
| 07/09/2018 |
BASi Announces Appointment of John E. Sagartz to Board of Directors
|
| 07/02/2018 |
Seventh Wave Laboratories Combine Operations to Provide Broader Solutions and Greater Scientific Expertise to Clients
|
| 04/30/2018 |
James Bourdage to Retire as BASi VP of Bioanalytical Operations; Michael Baim Named as Successor
|
| 04/04/2018 |
BASi and Phlebotics Form Strategic Alliance; Continuing a Commitment to Automated Blood Sampling
|
| 03/27/2018 |
Bolstering Preclinical PK/PD Operations: BASi Hires Karen L. Rogers, DVM, DACLAM, CPIA as Attending Veterinarian
|
| 12/12/2017 |
BASi Announces Enhanced Bioequivalence Capabilities
|
| 11/13/2017 |
Steady Growth Spurs Plans for BASi Expansion of GLP Toxicology Facility in Indiana
|
| 10/03/2017 |
Gaining Momentum: BASi Adds Candace Rohde-Johnson as Director of In Vivo Products and Services
|
| 09/19/2017 |
BASi Strengthens Preclinical PK/PD Leadership With the Hiring of James E. Burleigh as Director of Operations, Preclinical PK/PD
|
| 09/06/2017 |
BASi and JOANNEUM RESEARCH Enter Into Collaboration to Commercialize Open Flow Microperfusion Technology
|
| 08/28/2017 |
BASi Announces New Universal Caging System for Automated Sampling With Focus on Researcher-Friendly Design
|
| 08/03/2017 |
BASi Announces Election of R. Matthew Neff to the Board of Directors
|
| 07/31/2017 |
BASi Signs Reseller Agreement With LABEX of MA for Refurbished Culex® Automated Blood Sampling Systems
|
| 06/27/2017 |
BASi Completes Refinancing of Senior Secured Credit Facilities
|
| 06/20/2017 |
BASi Names Dr. Gregory C. Davis to Board of Directors
|
| 06/07/2017 |
BASi Announces Validated 'SEND' Capabilities and Compliance With FDA's Standard for Exchange of Nonclinical Data
|
| 05/01/2017 |
BASi Announces Appointment of Dr. Peter T. Kissinger as Scientific Advisor
|
| 03/08/2017 |
BASi Names Philip Downing Senior Vice President of Preclinical Services
|
| 12/21/2016 |
BASi Names Alan Loch Director of Business Development
|
| 08/25/2016 |
BASi Launches Embrace Automation Grant Program with Culex NxT™ Automated Blood Sampling System
|
| 07/27/2016 |
BASi Expands Electrochemical Offerings by Partnering with PalmSens BV
|
| 05/11/2016 |
BASi Announces Appointment of New Chief Financial Officer
|
| 04/14/2016 |
BASi Launches New Website and E-Catalogue
|
| 03/29/2016 |
BASi Introduces the Next Generation of Electrochemical Analyzer With the Release of the Epsilon EClipse™
|
| 02/04/2016 |
BASi Awards Raturn® Systems for Optogenetic Research
|
| 12/14/2015 |
BASi Names Wendy Perrow to Board of Directors
|
| 07/14/2015 |
BASi Announces Enhancements to the Company's Laboratory Information Management System (LIMS)
|
| 03/17/2015 |
BASi Names Philip A. Downing Vice President of Preclinical Services
|
| 02/12/2015 |
BASi Expands Scientific Expertise with the Hiring of Srini Jayaraman, Ph.D., Principal Investigator Discovery and Braden M. Kemmerling, D.V.M., Attending Veterinarian for Preclinical Services
|
| 12/02/2014 |
BASi’s Culex® L Large Animal Sampling System Combines an Ideal Model with an Ideal Tool for Improved Drug Development Research
|
| 06/12/2014 |
BASi Names Jeffrey Potrzebowski CFO and James Bourdage VP Bioanalytical Operations
|
| 05/30/2014 |
BASi Hosts In Vivo Drug Discovery Workshop at UCLA
|
| 10/16/2013 |
BASi Signs Preferred Provider Agreement with G1 Therapeutics
|
| 05/02/2013 |
BASi Launches Innovative Glucose Monitoring Project with Pinnacle Technology
|
| 12/18/2012 |
BASi to Release Fourth Quarter & Fiscal 2012 Results Thursday, December 27, 2012; Conference Call & Webcast Set For 11:00 a.m. EDT
|
